Searched for
FLUTICASONE
Glenmark Pharmaceuticals wins USFDA nod for fluticasone inhalerGlenmark Pharmaceuticals has secured a significant approval from the US FDA for its inhaler fluticasone propionate. This marks a key step i...- GSK launches once daily, single inhaler-triple therapy for COPD patientsTrelegy is delivered via the innovative Ellipta inhaler that provides accurate dosing through its consistent dose delivery mechanism and is...
- GSK files patent suit against GlenmarkGSK was granted a patent for vilanterol in India in 2007. The patent expires in September 2022.
- Cipla submits application with USFDA for generic version of asthma drugDrug major Cipla on Monday said it has submitted an application with the US health regulator for a generic version of GSK's Advair Diskus, ...
- Glenmark Pharma rallies on Germany marketing nodThe drug, Fluticasone/Salmeterol dry powder inhaler (DPI), is a generic version of GlaxoSmithKline’s Seretide Accuhaler.
- Glenmark inks licensing pact for generic Tiotropium Bromide dry powder inhaler in Western EuropeThis is the second inhalation product in-licensed by Glenmark for the European market after Fluticasone/Salmeterol dry powder inhaler, the ...
- Glenmark Pharma launches generic version of asthma drug in DenmarkThe product was developed by Celon Pharma and Glenmark has marketing and distribution rights for the product across 15 European countries.
- Glenmark Pharmaceuticals inks pact with Celon for generic Seretide AccuhalerAs per the agreement, Glenmark has obtained semi-exclusive marketing and distribution rights of the product across 15 European countries
- GSK halves seretide price to take on CiplaAsthma patients may breathe easier as GSK has halved the prices of its Seretide inhaler in India to match that of Cipla’s competing brand S...
- Lupin ties up with Poland-based firm for generic asthama drugLupin has set up a dedicated centre of excellence for inhalation research in Florida after having hired top notch inhalation scientists las...
- Cipla surges on launch of anti-asthma inhaler in Germany, SwedenThe launch paves way for a re-rating of the stock as the drugmaker could look at other key markets like UK, France and Spain next, say anal...
- Brokerages raise Cipla's target price post inhaler launchAnalysts at Emkay Global Financial Services are of the view that the launch will have a strong positive impact on the company’s margins.
- Glenmark eyes 20% sales growth in India speciality business in 3 yearsGlenmark Pharmaceuticals expects sales of its speciality business, which focuses on branded products, to grow by around 20 per cent in Indi...
- Hits & Misses: Alfa Laval, WockhardtShares of Alfa Laval spurted 14.4% to Rs 2,710.85 after its parent Alfa Laval Corp AB raised the price to buy back the remaining public sha...
- Wockhardt receives USFDA approval for Fluticasone nasal sprayWockhardt received final approval from the USFDA to market generic Fluticasone nasal spray, used for treating allergic nasal inflammation, ...
- Wockhardt gains on Rhinitis drug launchShares of Wockhardt gained over 4% after the pharmaceutical major received final approval from the US FDA for marketing nasal spray of Flut...
- Glenmark settles patent suit for skin lotion with NycomedFluticasone propionate 0.05 per cent lotion by Glenmark is generic version of Nycomed's 'Cultivate' lotion.
- Glenmark gets USFDA nod for Fluticasone propionate lotionGlenmark said it has received final approval from the USFDA for lotion used for skin treatment.
- Glenmark confirms patent challenge of fluticasone lotionGlenmark Generics Ltd's US subsidiary confirmed Nycomed US filed a patent infringement lawsuit on Dec 12, 2008, in the US District Court, E...
- Ranbaxy launches new drug for asthmaRanbaxy Laboratories Ltd on Tuesday announced the launch of its branded product, Avessa inhalation capsules in India for the treatment of A...
Load More
